Celldex Therapeutics, Inc. - COM NEW (CLDX)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / COM NEW
Number of holders
161
Total Shares
60.1M
Shares change
+9.88M
Total reported value, excl. options
$2.39B
Value change
+$394M
Put/Call ratio
0.9
Number of buys
87
Number of sells
-56
Price
$39.66
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.